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CONCLUSION 
•Bioactive peptideTM show promise as a 
natural treatment for chronic skin wounds
•Treatment A proved to be most effective
•Rat models shown effective as a means 
to test wound healing parameters
INTRODUCTION
•Treatment of chronic, open wounds is often 
complicated by comorbities presenting 
therapeutic challenges
•Burden in US around $20 billion (1, 3)
•Currently only 4 FDA approved therapies for 
chronic cutaneous wounds (2)
•Bioactive peptides preferentially incorporated 
during each phase of skin wound repair
MATERIALS AND 
METHODS 
•30, 200 g Sprague-Dawley outbred albino rats 
randomized to 5 test groups (A-E)
•Treatment applied to left dorsal intrascapular region 
following 4 mm full-thickness skin incision
•Right sided incision on same animal served as 
control
•All wounds allowed to heal via secondary intention
•Animals euthanized day 7 post surgery
•Histological analysis of healing in both wounds 
conducted by randomized point count
•One-way ANOVA with Tukey-Kramer post-hoc test 
to confirm differences between group means 
(p<0.05)
RESULTS
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FUTURE DIRECTIONS 
• Future studies to be conducted to determine 
full mechanism of treatment
• This preliminary trial warrants a larger scale 
and longer duration study
• FDA trials also planned to begin testing in 
human trials
• Treatments listed from most effective to least effective: A,C,D,E,B. 
• Treatment C showed significantly greater dense connective tissue 
than treatments B and E (p<0.01). Treatment A showed significantly 
greater dense CT than treatments B and E (p<0.01 in both). 
• Treatment E showed a significantly greater number of fat cells than 
treatment A (p<0.01) and treatment C (p<0.006).
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Figure 2. Mean Concentration of Fat Cells Per Treatment Group in Wound Site.
Figure 1. Mean Concentration of Dense Connective Tissue Per Treatment Group in Wound Site.
Figure 3. Histological Imaging of Wound Site Used in Point Count.
